Guardant Health Inc. (5GH)
XDUS
Real-time Data
06:00 AM
Day's Range
139.2052 wk Range
45.35Overview - 5GH - Guardant Health Inc.
Key Statistics
Valuation
Enterprise Value
1.33B
P/E (Trailing)
‪-42.32‬
PEG Ratio
‪-3.38‬
Price / Book
‪-83.77‬
EV / EBITDA
‪-3.56‬
Profitability
Gross Margin
‪65.38%‬
Profit Margin
‪64.46%‬
Operating Margin
‪-42.12%‬
Return on Assets
‪-20.67%‬
Return on Equity
‪419.18%‬
Ownership
Shares Outstanding
133.61M
Price stats
50-Day Avg
‪134.27‬
200-Day Avg
‪98.63‬
Peers - 5GH - Guardant Health Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on XDUS.
- 5GHXDUSGuardant Health Inc.+64.09%52-week change-41.53P/E (Trailing)‪64.46%‬Profit Margin
- NL0XDUSGrail, Inc.+57.14%52-week change-5.92P/E (Trailing)‪-236.94%‬Profit Margin
- 0MEXDUSTwist Bioscience Corporation+82.13%52-week change-101.08P/E (Trailing)‪50.72%‬Profit Margin
- 1K9XDUSCareDx Inc.+74.13%52-week change-109.00P/E (Trailing)‪67.55%‬Profit Margin
- 04XXDUSPersonalis Inc.+71.88%52-week change-15.98P/E (Trailing)‪22.65%‬Profit Margin
- NG9XDUSNeoGenomics Inc.+60.23%52-week change-16.91P/E (Trailing)‪43.21%‬Profit Margin
- NG2XDUSNeogen Corporation+51.76%52-week change-245.65P/E (Trailing)‪46.93%‬Profit Margin
Profile Summary - 5GH - Guardant Health Inc.
About
Guardant Health Inc. is a precision oncology company that develops and provides blood and tissue-based tests, along with vast data sets and advanced analytics, to support cancer treatment, monitoring, and early detection. Its core offerings include the Guardant360 family of liquid biopsy tests, such as Guardant360 CDx…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
